Compare Pfizer with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ALEMBIC LTD - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ALEMBIC LTD PFIZER/
ALEMBIC LTD
 
P/E (TTM) x 33.7 67.5 50.0% View Chart
P/BV x 5.7 2.4 236.0% View Chart
Dividend Yield % 0.6 0.4 141.7%  

Financials

 PFIZER   ALEMBIC LTD
EQUITY SHARE DATA
    PFIZER
Mar-18
ALEMBIC LTD
Mar-18
PFIZER/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs2,36572 3,284.7%   
Low Rs1,62534 4,793.5%   
Sales per share (Unadj.) Rs430.34.7 9,153.6%  
Earnings per share (Unadj.) Rs78.76.1 1,289.5%  
Cash flow per share (Unadj.) Rs93.26.2 1,492.1%  
Dividends per share (Unadj.) Rs20.000.20 10,000.0%  
Dividend yield (eoy) %1.00.4 265.4%  
Book value per share (Unadj.) Rs586.540.7 1,442.4%  
Shares outstanding (eoy) m45.75267.03 17.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.611.3 41.2%   
Avg P/E ratio x25.38.7 292.2%  
P/CF ratio (eoy) x21.48.5 252.5%  
Price / Book Value ratio x3.41.3 261.2%  
Dividend payout %25.43.3 775.5%   
Avg Mkt Cap Rs m91,27114,139 645.5%   
No. of employees `0002.6NA-   
Total wages/salary Rs m3,143207 1,515.4%   
Avg. sales/employee Rs Th7,484.8NM-  
Avg. wages/employee Rs Th1,195.0NM-  
Avg. net profit/employee Rs Th1,369.1NM-  
INCOME DATA
Net Sales Rs m19,6851,255 1,568.3%  
Other income Rs m1,143370 308.7%   
Total revenues Rs m20,8281,625 1,281.4%   
Gross profit Rs m5,003111 4,503.1%  
Depreciation Rs m66338 1,752.6%   
Interest Rs m42 247.1%   
Profit before tax Rs m5,479442 1,240.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,87824 7,843.0%   
Profit after tax Rs m3,6011,630 220.9%  
Gross profit margin %25.48.9 287.1%  
Effective tax rate %34.35.4 632.4%   
Net profit margin %18.3129.8 14.1%  
BALANCE SHEET DATA
Current assets Rs m24,1671,867 1,294.4%   
Current liabilities Rs m9,544591 1,614.4%   
Net working cap to sales %74.3101.6 73.1%  
Current ratio x2.53.2 80.2%  
Inventory Days Days5594 58.4%  
Debtors Days Days2974 39.0%  
Net fixed assets Rs m9,5141,791 531.2%   
Share capital Rs m458534 85.7%   
"Free" reserves Rs m26,37510,324 255.5%   
Net worth Rs m26,83210,858 247.1%   
Long term debt Rs m2541 60.7%   
Total assets Rs m36,90011,591 318.4%  
Interest coverage x1,305.5260.9 500.4%   
Debt to equity ratio x00 24.6%  
Sales to assets ratio x0.50.1 492.6%   
Return on assets %9.814.1 69.4%  
Return on equity %13.415.0 89.4%  
Return on capital %20.415.2 134.4%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m2219 115.5%   
Fx outflow Rs m1,489264 564.3%   
Net fx Rs m-1,466-244 599.9%   
CASH FLOW
From Operations Rs m3,318236 1,407.1%  
From Investments Rs m-2,383-224 1,063.8%  
From Financial Activity Rs m-1,104-27 4,148.5%  
Net Cashflow Rs m-169-15 1,138.5%  

Share Holding

Indian Promoters % 0.0 64.0 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.2 3,750.0%  
FIIs % 4.9 9.7 50.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 26.1 90.8%  
Shareholders   85,207 54,701 155.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   J.B.CHEMICALS  VENUS REMEDIES  STERLING BIOTECH  CADILA HEALTHCARE  SUVEN LIFESCIENCES  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

WPI Inflation Data, Global Stock Market Drivers, and Top Cues in Focus Today(Pre-Open)

On Monday, Indian share markets witnessed negative trading activity throughout the day and ended lower.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Sep 16, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS